![Jason Amello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Amello
Finanzdirektor/CFO bei
TSCAN THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2026
Profil
Jason A. Amello is Chief Financial & Accounting Officer, Treasurer at TScan Therapeutics, Inc. since 2026.
Former roles include Director at Opexa Therapeutics, Inc.; Independent Director at Acer Therapeutics, Inc. from 2017 to 2023; Director at New England Baptist Hospital from 2015 to 2023; Senior Manager at Deloitte LLP (New York) from 1990 to 2000; Chief Financial Officer, Treasurer & Executive VP at Alaunos Therapeutics, Inc. in 2013; Treasurer, Chief Financial & Accounting Officer at Akebia Therapeutics, Inc. from 2013 to 2020; Chief Financial & Accounting Officer, Secretary at Candel Therapeutics, Inc. from 2022 to 2024; Chief Financial Officer at Saniona AB from 2020 to 2022; and Chief Accounting Officer, Senior VP & Controller at Genzyme Corp.
from 2000 to 2011.
Education includes undergraduate studies at Boston College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Jason Amello
| Unternehmen | Position | Beginn |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Finanzdirektor/CFO | 29.01.2024 |
Ehemalige bekannte Positionen von Jason Amello
| Unternehmen | Position | Ende |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Finanzdirektor/CFO | 12.01.2024 |
| ACER THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 17.11.2023 |
New England Baptist Hospital
 New England Baptist Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services | Direktor/Vorstandsmitglied | 01.01.2023 |
| SANA AB | Finanzdirektor/CFO | 01.04.2022 |
| AKEBIA THERAPEUTICS, INC. | Finanzdirektor/CFO | 29.06.2020 |
Ausbildung von Jason Amello
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides audit, consulting, tax and financial advisory services | Commercial Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
New England Baptist Hospital
New England Baptist Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
